Business · 29/04/2026
FDA Requests Input on AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program
The FDA is seeking input on a pilot program to assess the use of AI technologies to improve efficiency and quality in early-phase clinical trials, a critical bottleneck in drug development.